Chris MacDonald

Chris MacDonald

Chris MacDonald is an MBA (finance) graduate with extensive experience covering small-, mid- and large-cap companies in the U.S. and Canadian markets. Chris is interesting in uncovering long-term and deep-value opportunities for investors based on principles from the Graham-Buffett school of thought, and looks forward to bringing investors a unique fundamental-based perspective on opportunities available in today’s challenging investing environment.

His experience as a financial analyst in the past, coupled with his fervor for finding undervalued growth opportunities, contribute to his conservative, long-term investing perspective.

Recent Articles

Beyond Tesla: 3 EV Stocks Offering Greater Long-Term Returns

Three EV stocks investors shouldn't sleep on, and none of these companies happen to be named Tesla.

Post-Nvidia Boom: 3 Potential Windfall Stocks Ready to Surge

The search is on for high-growth stocks to buy, but there are plenty of options to consider beyond Nvidia right now.

Why Is Sotera Health (SHC) Stock Up 20% Today?

Shares of SHC stock are surging higher today, as Sotera Health announced a settlement for ongoing claims against its subsidiary.

TRxADE Health (MEDS) Stock Soars 60% on Reverse Split

Investors in TRxADE Health are seeing a lot of green on the screen today, as MEDS stock surges more than 50% following a split.

Invest Like a Billionaire: 3 Long-Term Stocks Warren Buffett Loves

Warren Buffett is undoubtedly one of the greatest investors of all time, due in large part to the performance of these three companies.